Applied Statistical Inference: Likelihood and Bayes L Held, D Sabanés Bové Berlin, Heidelberg: Springer Berlin Heidelberg, 2014 | 266* | 2014 |
Software for Bayesian Inference in Structured Additive Regression Models C Belitz, A Brezger, T Kneib, S Lang, EM Fronk, F Heinzl, A Hennerfeind, ... | 180* | |
Hyper-g priors for generalized linear models D Sabanés Bové, L Held Bayesian Analysis 6 (3), 387-410, 2011 | 130 | 2011 |
Pilot study on HTR2A promoter polymorphism,− 1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive–compulsive … S Walitza, DS Bové, M Romanos, T Renner, L Held, M Simons, ... Journal of Neural Transmission 119, 507-515, 2012 | 49 | 2012 |
Reduction of Thromboembolic Events in Meningioma Surgery: A Cohort Study of 724 Consecutive Patients CV Eisenring, MC Neidert, DS Bové, L Held, J Sarnthein, N Krayenbühl PLOS ONE 8 (11), e79170, 2013 | 48 | 2013 |
Likelihood and Bayesian inference: with applications in biology and medicine L Held, DS Bové Springer Nature, 2020 | 38* | 2020 |
Bayesian fractional polynomials DS Bové, L Held Statistics and Computing 21 (3), 309-324, 2011 | 34 | 2011 |
Sensitization to Common Ragweed in Southern Bavaria: Clinical and Geographical Risk Factors in Atopic Patients F Ruëff, B Przybilla, A Walker, J Gmeiner, M Kramer, D Sabanés-Bové, ... International Archives of Allergy and Immunology 159 (1), 65-74, 2012 | 32 | 2012 |
Approximate Bayesian model selection with the deviance statistic L Held, DS Bové, I Gravestock Statistical Science 30 (2), 242-257, 2015 | 28 | 2015 |
Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with … G Argiles, J Saro, NH Segal, I Melero, W Ros, A Marabelle, ME Rodriguez, ... Annals of Oncology 28, iii151, 2017 | 27 | 2017 |
Objective Bayesian Model Selection in Generalised Additive Models with Penalised Splines DS Bové, L Held, G Kauermann Journal of Computational and Graphical Statistics, 00-00, 2014 | 20* | 2014 |
Objective Bayesian model selection for Cox regression L Held, I Gravestock, D Sabanés Bové Statistics in Medicine 35 (29), 5376-5390, 2016 | 17 | 2016 |
Bayesian adaptive dose‐escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy WY Yeung, B Reigner, U Beyer, C Diack, D Sabanés bové, G Palermo, ... Pharmaceutical statistics 16 (6), 396-413, 2017 | 14 | 2017 |
Validating and updating a risk model for pneumonia–a case study U Held, D Bové, J Steurer, L Held BMC Medical Research Methodology 12 (1), 99, 2012 | 12 | 2012 |
Model-Based Dose Escalation Designs in R with crmPack D Sabanés Bové, WY Yeung, G Palermo, T Jaki Journal of Statistical Software 89 (10), 2019 | 11 | 2019 |
Choice of generalized linear mixed models using predictive crossvalidation J Braun, D Sabanés Bové, L Held Computational Statistics & Data Analysis 75, 190-202, 2014 | 5 | 2014 |
Rolling continual reassessment method with overdose control: An efficient and safe dose escalation design J Zhu, DS Bové, Z Liao, U Beyer, G Yung, S Sarkar Contemporary Clinical Trials, 106436, 2021 | 2 | 2021 |
Comment on Cai and Betensky (2003), On the Poisson Approximation for Hazard Regression DS Bové, L Held Biometrics 69 (3), 795-795, 2013 | 2 | 2013 |
Improving Software Engineering in Biostatistics: Challenges and Opportunities DS Bové, H Seibold, AL Boulesteix, J Manitz, A Gasparini, BK Guünhan, ... arXiv preprint arXiv:2301.11791, 2023 | 1 | 2023 |
A model-based view on outbreak detection L Held, M Paul, DS Bové Conference of Statistical Methods for Outbreak Detection, 2010 | 1 | 2010 |